(2S)-2-[5-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-imidazol-2-yl]pyrrolidine-1-carboxylic acid

C20H26BN3O4 — CID 66848089

IUPAC(2S)-2-[5-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-imidazol-2-yl]pyrrolidine-1-carboxylic acid
SMILESCC1(C)OB(c2ccc(-c3cnc([C@@H]4CCCN4C(=O)O)[nH]3)cc2)OC1(C)C
InChIInChI=1S/C20H26BN3O4/c1-19(2)20(3,4)28-21(27-19)14-9-7-13(8-10-14)15-12-22-17(23-15)16-6-5-11-24(16)18(25)26/h7-10,12,16H,5-6,11H2,1-4H3,(H,22,23)(H,25,26)/t16-/m0/s1
InChIKeyCRFISUQRPNRFEN-INIZCTEOSA-N
MW383.26 g/mol
LogP3.19
Rot. Bonds3

About (2S)-2-[5-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-imidazol-2-yl]pyrrolidine-1-carboxylic acid

(2S)-2-[5-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-imidazol-2-yl]pyrrolidine-1-carboxylic acid (PubChem CID 66848089) has the molecular formula C20H26BN3O4 and a molecular weight of 383.26 g/mol. Its IUPAC name is (2S)-2-[5-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-imidazol-2-yl]pyrrolidine-1-carboxylic acid.

Molecular Properties

Compound Name(2S)-2-[5-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-imidazol-2-yl]pyrrolidine-1-carboxylic acid
PubChem CID66848089
Molecular FormulaC20H26BN3O4
Molecular Weight383.26 g/mol
Exact Mass383.20
IUPAC Name(2S)-2-[5-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-imidazol-2-yl]pyrrolidine-1-carboxylic acid
SMILESCC1(C)OB(c2ccc(-c3cnc([C@@H]4CCCN4C(=O)O)[nH]3)cc2)OC1(C)C
InChIInChI=1S/C20H26BN3O4/c1-19(2)20(3,4)28-21(27-19)14-9-7-13(8-10-14)15-12-22-17(23-15)16-6-5-11-24(16)18(25)26/h7-10,12,16H,5-6,11H2,1-4H3,(H,22,23)(H,25,26)/t16-/m0/s1
InChIKeyCRFISUQRPNRFEN-INIZCTEOSA-N
XLogP3.19
TPSA87.68 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds3
Heavy Atoms28
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500383.26
LogP ≤ 53.19
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze (2S)-2-[5-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-imidazol-2-yl]pyrrolidine-1-carboxylic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S)-2-[5-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-imidazol-2-yl]pyrrolidine-1-carboxylic acid?
The IUPAC name of (2S)-2-[5-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-imidazol-2-yl]pyrrolidine-1-carboxylic acid (CID 66848089) is (2S)-2-[5-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-imidazol-2-yl]pyrrolidine-1-carboxylic acid.
What is the SMILES notation for (2S)-2-[5-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-imidazol-2-yl]pyrrolidine-1-carboxylic acid?
The canonical SMILES for (2S)-2-[5-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-imidazol-2-yl]pyrrolidine-1-carboxylic acid is CC1(C)OB(c2ccc(-c3cnc([C@@H]4CCCN4C(=O)O)[nH]3)cc2)OC1(C)C.
What is the InChIKey of (2S)-2-[5-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-imidazol-2-yl]pyrrolidine-1-carboxylic acid?
The InChIKey is CRFISUQRPNRFEN-INIZCTEOSA-N. The full InChI is InChI=1S/C20H26BN3O4/c1-19(2)20(3,4)28-21(27-19)14-9-7-13(8-10-14)15-12-22-17(23-15)16-6-5-11-24(16)18(25)26/h7-10,12,16H,5-6,11H2,1-4H3,(H,22,23)(H,25,26)/t16-/m0/s1.
What are the key properties of (2S)-2-[5-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-imidazol-2-yl]pyrrolidine-1-carboxylic acid?
(2S)-2-[5-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-imidazol-2-yl]pyrrolidine-1-carboxylic acid has a molecular weight of 383.26 g/mol, XLogP of 3.19, 3 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-2-[5-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-imidazol-2-yl]pyrrolidine-1-carboxylic acid is sourced from PubChem (CID 66848089), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).